Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Unicycive Therapeutics (UNCY) Other Gross PP&E Adjustments (2020 - 2026)

Unicycive Therapeutics filings provide 4 years of Other Gross PP&E Adjustments readings, the most recent being -$1.3 million for Q4 2024.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 9.56% to -$1.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$1.3 million, a 9.56% decrease, with the full-year FY2024 number at -$1.3 million, down 9.56% from a year prior.
  • Other Gross PP&E Adjustments hit -$1.3 million in Q4 2024 for Unicycive Therapeutics, down from -$680000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$176000.0 in Q3 2022 to a low of -$1.3 million in Q4 2024.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$665000.0 (2024), compared with a mean of -$664846.2.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 368.18% in 2023 and later soared 40.58% in 2024.
  • Unicycive Therapeutics' Other Gross PP&E Adjustments stood at -$502000.0 in 2021, then rose by 1.2% to -$496000.0 in 2022, then tumbled by 132.06% to -$1.2 million in 2023, then dropped by 9.56% to -$1.3 million in 2024.
  • The last three reported values for Other Gross PP&E Adjustments were -$1.3 million (Q4 2024), -$680000.0 (Q3 2024), and -$536000.0 (Q2 2024) per Business Quant data.